Preclinical testing of erlotinib in a transgenic alveolar rhabdomyosarcoma mouse model. (Q34929504)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21559212%20AND%20SRC:MED&resulttype=core&format=json

31 January 2020

title

Preclinical testing of erlotinib in a transgenic alveolar rhabdomyosarcoma mouse model (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21559212%20AND%20SRC:MED&resulttype=core&format=json

alveolar rhabdomyosarcoma

31 January 2020

main subject

1 reference

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21559212%20AND%20SRC:MED&resulttype=core&format=json

31 January 2020

author name string

Jinu Abraham

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21559212%20AND%20SRC:MED&resulttype=core&format=json

31 January 2020

Laura D Nelon

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21559212%20AND%20SRC:MED&resulttype=core&format=json

31 January 2020

Courtney B Kubicek

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21559212%20AND%20SRC:MED&resulttype=core&format=json

31 January 2020

Aoife Kilcoyne

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21559212%20AND%20SRC:MED&resulttype=core&format=json

31 January 2020

Sheila T Hampton

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21559212%20AND%20SRC:MED&resulttype=core&format=json

31 January 2020

Lee Ann Zarzabal

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21559212%20AND%20SRC:MED&resulttype=core&format=json

31 January 2020

Francis J Giles

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21559212%20AND%20SRC:MED&resulttype=core&format=json

31 January 2020

Joel E Michalek

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21559212%20AND%20SRC:MED&resulttype=core&format=json

31 January 2020

Brian P Rubin

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21559212%20AND%20SRC:MED&resulttype=core&format=json

31 January 2020

publication date

20 April 2011

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21559212%20AND%20SRC:MED&resulttype=core&format=json

31 January 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21559212%20AND%20SRC:MED&resulttype=core&format=json

31 January 2020

volume

2011

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21559212%20AND%20SRC:MED&resulttype=core&format=json

31 January 2020

page(s)

130484

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21559212%20AND%20SRC:MED&resulttype=core&format=json

Creative Commons Attribution 3.0 Unported

31 January 2020

copyright license

start time

1 January 2011

1 reference

April 2022 Public Data File from Crossref

copyright status

copyrighted

1 reference

April 2022 Public Data File from Crossref

cites work

Update on the treatment of gastrointestinal stromal tumors (GISTs): role of imatinib.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3087964

EGFR signaling and drug discovery.

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3087964

Credentialing a preclinical mouse model of alveolar rhabdomyosarcoma

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3087964

Pediatric phase I and pharmacokinetic study of erlotinib followed by the combination of erlotinib and temozolomide: a Children's Oncology Group Phase I Consortium Study

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3087964

Erlotinib plus gemcitabine compared with gemcitabine alone in patients with advanced pancreatic cancer: a phase III trial of the National Cancer Institute of Canada Clinical Trials Group

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3087964

Erlotinib in previously treated non-small-cell lung cancer

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3087964

Pax3:Fkhr interferes with embryonic Pax3 and Pax7 function: implications for alveolar rhabdomyosarcoma cell of origin.

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3087964

Alveolar rhabdomyosarcomas in conditional Pax3:Fkhr mice: cooperativity of Ink4a/ARF and Trp53 loss of function.

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3087964

Antitumor activity of erlotinib (OSI-774, Tarceva) alone or in combination in human non-small cell lung cancer tumor xenograft models

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3087964

Metastatic rhabdomyosarcoma: a retrospective review of patients treated at the hospital for sick children between 1989 and 1999.

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3087964

Common musculoskeletal tumors of childhood and adolescence

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3087964

Prognostic factors and clinical outcomes in children and adolescents with metastatic rhabdomyosarcoma--a report from the Intergroup Rhabdomyosarcoma Study IV.

8 July 2018

1 reference

Crossref

https://api.crossref.org/works/10.1155%2F2011%2F130484

Six-year follow-up of patients receiving imatinib for the first-line treatment of chronic myeloid leukemia

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1155%2F2011%2F130484

Expression of receptor tyrosine kinases and apoptotic molecules in rhabdomyosarcoma: correlation with overall survival in 105 patients.

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1155%2F2011%2F130484

Induction of apoptosis and cell cycle arrest by CP-358,774, an inhibitor of epidermal growth factor receptor tyrosine kinase

21 January 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/21559212

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Phosphorylation profiles of protein kinases in alveolar and embryonal rhabdomyosarcoma

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/21559212

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1155/2011/130484

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21559212%20AND%20SRC:MED&resulttype=core&format=json

31 January 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21559212%20AND%20SRC:MED&resulttype=core&format=json

31 January 2020

1 reference